A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers

NCT04461353 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2

Interventions

DRUG: Aerolized Hydroxychloroquine Sulfate
OTHER: Placebo

Sponsor

Pulmoquine Therapeutics, Inc

Collaborators

[object Object]